PTSD May Increase Symptom Burden in Patients With Cancer

Share this content:
PTSD can decrease the risk of hospital readmissions, research indicates.
PTSD can decrease the risk of hospital readmissions, research indicates.

(HealthDay News) -- Post-traumatic stress disorder (PTSD) symptoms among hospitalized patients with cancer are associated with a greater psychological and physical symptom burden as well as a decreased risk of hospital readmissions, according to a study published online June 15 in Cancer.

Ryan D. Nipp, M.D., M.P.H., from Massachusetts General Hospital Cancer Center in Boston, and colleagues explored relationships among PTSD symptoms, physical and psychological symptom burden, and risk for hospital readmissions among 954 prospectively enrolled patients with cancer admitted for an unplanned hospitalization from August 2015 to April 2017.

The researchers found that 13.3 percent of patients screened positive for PTSD symptoms. The 90-day hospital readmission rate was 38.9 percent. Higher PTSD scores were seen among patients with younger age, female sex, greater comorbidities, and genitourinary cancer type. There was an association between patients' PTSD symptoms and physical symptoms, total symptom burden, depression, and anxiety symptoms. PTSD symptoms were associated with a lower risk of hospital readmissions (hazard ratio, 0.81).

"Interventions to address patients' PTSD symptoms are needed and should account for their physical and psychological symptom burden," write the authors.

Abstract/Full Text (subscription or payment may be required)

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs